French generics and biosimilars association Gemme has renewed its opposition to the country’s “safeguard clause” rebate mechanism, backing suggestions by the department of social security that the system is in need of reform.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?